These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26650253)

  • 1. A role for sigma receptors in stimulant self-administration and addiction.
    Katz JL; Hong WC; Hiranita T; Su TP
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):100-15. PubMed ID: 26650253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Role for Sigma Receptors in Stimulant Self Administration and Addiction.
    Katz JL; Su TP; Hiranita T; Hayashi T; Tanda G; Kopajtic T; Tsai SY
    Pharmaceuticals (Basel); 2011; 4(6):880-914. PubMed ID: 21904468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats.
    Hiranita T; Soto PL; Tanda G; Kopajtic TA; Katz JL
    J Pharmacol Exp Ther; 2013 Oct; 347(1):20-9. PubMed ID: 23908387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine.
    Hiranita T; Soto PL; Tanda G; Katz JL
    J Pharmacol Exp Ther; 2010 Feb; 332(2):515-24. PubMed ID: 19892920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.
    Hiranita T; Mereu M; Soto PL; Tanda G; Katz JL
    Neuropsychopharmacology; 2013 Mar; 38(4):605-15. PubMed ID: 23187725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
    Hiranita T; Soto PL; Kohut SJ; Kopajtic T; Cao J; Newman AH; Tanda G; Katz JL
    J Pharmacol Exp Ther; 2011 Nov; 339(2):662-77. PubMed ID: 21859929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats.
    Hiranita T; Soto PL; Tanda G; Katz JL
    Behav Pharmacol; 2011 Sep; 22(5-6):525-30. PubMed ID: 21808192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.
    Katz JL; Hiranita T; Kopajtic TA; Rice KC; Mesangeau C; Narayanan S; Abdelazeem AH; McCurdy CR
    J Pharmacol Exp Ther; 2016 Jul; 358(1):109-24. PubMed ID: 27189970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration.
    Hiranita T; Hong WC; Kopajtic T; Katz JL
    J Pharmacol Exp Ther; 2017 Jul; 362(1):2-13. PubMed ID: 28442581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies.
    McBride WJ; Murphy JM; Ikemoto S
    Behav Brain Res; 1999 Jun; 101(2):129-52. PubMed ID: 10372570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional imaging and neurochemical correlates of stimulant self-administration in primates.
    Howell LL; Wilcox KM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats.
    Cao DN; Song R; Zhang SZ; Wu N; Li J
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3017-29. PubMed ID: 27329413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR; Miller DK
    Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic dopamine modulation by stimulant self-administration.
    Espana RA; Jones SR
    Front Biosci (Schol Ed); 2013 Jan; 5(1):261-76. PubMed ID: 23277050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.
    Maurice T; Martin-Fardon R; Romieu P; Matsumoto RR
    Neurosci Biobehav Rev; 2002 Jun; 26(4):499-527. PubMed ID: 12204195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.